Wikidata entity: Q409231
C₁₉H₁₆ClNO₄ (P274)
Quantities
| P2067 | mass | 357.077 |
| P2101 | melting point | 160 |
| P3780 | active ingredient in | ... | Q47521710 (Indocin) | Indocin |
| P3780 | active ingredient in | ... | Q47522209 (Tivorbex) | Tivorbex |
| P233 | canonical SMILES | String | CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O | ??? |
| P373 | Commons category | String | Indometacin | ??? |
| P703 | found in taxon | ... | Q137155 (Penicillium chrysogenum) | Penicillium chrysogenum |
| P703 | found in taxon | ... | Q157154 (Plantago major) | Plantago major |
| P703 | found in taxon | ... | Q311677 (Physalis angulata) | Physalis angulata |
| P703 | found in taxon | ... | Q335130 (Aspergillus) | Aspergillus |
| P703 | found in taxon | ... | Q4915492 (Bipolaris) | Bipolaris |
| P703 | found in taxon | ... | Q1281083 (Alpinia officinarum) | Alpinia officinarum |
| P703 | found in taxon | ... | Q5234097 (Alternaria brassicicola) | Alternaria brassicicola |
| P703 | found in taxon | ... | Q7162871 (Penicillium purpurogenum) | Penicillium purpurogenum |
| P703 | found in taxon | ... | Q15234968 (Perilla frutescens var. acuta) | Perilla frutescens var. acuta |
| P703 | found in taxon | ... | Q2749932 (Trichoderma reesei) | Trichoderma reesei |
| P527 | has part(s) | ... | Q623 (carbon) | carbon |
| P527 | has part(s) | ... | Q627 (nitrogen) | nitrogen |
| P527 | has part(s) | ... | Q629 (oxygen) | oxygen |
| P527 | has part(s) | ... | Q688 (chlorine) | chlorine |
| P366 | has use | ... | Q12140 (medication) | medication |
| P8224 | image of molecular model or crystal lattice model | CommonsMedia | http://commons.wikimedia.org/wiki/Special:FilePath/Indomethacin%20sticks-model.png | ??? |
| P31 | instance of | ... | Q113145171 (type of chemical entity) | type of chemical entity |
| P3493 | legal status (medicine) | ... | Q879952 (boxed warning) | boxed warning |
| P8026 | LiverTox likelihood score | ... | Q83284310 (LiverTox toxicity likelihood category C) | LiverTox toxicity likelihood category C |
| P176 | manufacturer | ... | Q206921 (Pfizer) | Pfizer |
| P2175 | medical condition treated | ... | Q81938 (pain) | pain |
| P2175 | medical condition treated | ... | Q101991 (inflammation) | inflammation |
| P2175 | medical condition treated | ... | Q133087 (gout) | gout |
| P2175 | medical condition treated | ... | Q187255 (rheumatoid arthritis) | rheumatoid arthritis |
| P2175 | medical condition treated | ... | Q52844 (enthesopathy) | enthesopathy |
| P2175 | medical condition treated | ... | Q62736 (osteoarthritis) | osteoarthritis |
| P2175 | medical condition treated | ... | Q645363 (bursitis) | bursitis |
| P2175 | medical condition treated | ... | Q6081223 (gout attack) | gout attack |
| P2175 | medical condition treated | ... | Q2072063 (patent ductus arteriosus) | patent ductus arteriosus |
| P2175 | medical condition treated | ... | Q2892779 (nephrogenic diabetes insipidus) | nephrogenic diabetes insipidus |
| P129 | physically interacts with | ... | Q21990456 (Prostaglandin D2 receptor 2) | Prostaglandin D2 receptor 2 |
| P129 | physically interacts with | ... | Q1084878 (Peroxisome proliferator activated receptor gamma) | Peroxisome proliferator activated receptor gamma |
| P129 | physically interacts with | ... | Q21121086 (solute carrier family 46 member 1) | solute carrier family 46 member 1 |
| P129 | physically interacts with | ... | Q21174141 (Prostaglandin D2 receptor 2) | Prostaglandin D2 receptor 2 |
| P3489 | pregnancy category | ... | Q3679261 (Australian pregnancy category C) | Australian pregnancy category C |
| P769 | significant drug interaction | ... | Q155472 (valsartan) | valsartan |
| P769 | significant drug interaction | ... | Q186969 (ibuprofen) | ibuprofen |
| P769 | significant drug interaction | ... | Q45050 (tenoxicam) | tenoxicam |
| P769 | significant drug interaction | ... | Q58396 (imipramine) | imipramine |
| P769 | significant drug interaction | ... | Q18216 (aspirin) | aspirin |
| P769 | significant drug interaction | ... | Q190016 (heparin) | heparin |
| P769 | significant drug interaction | ... | Q277785 (perindopril) | perindopril |
| P769 | significant drug interaction | ... | Q304088 (acenocoumarol) | acenocoumarol |
| P769 | significant drug interaction | ... | Q307088 (abciximab) | abciximab |
| P769 | significant drug interaction | ... | Q221520 (triamterene) | triamterene |
| P769 | significant drug interaction | ... | Q275926 (bumetanide) | bumetanide |
| P769 | significant drug interaction | ... | Q58397 (amitriptyline) | amitriptyline |
| P769 | significant drug interaction | ... | Q58713 (clomipramine) | clomipramine |
| P769 | significant drug interaction | ... | Q27074832 (azilsartan) | azilsartan |
| P769 | significant drug interaction | ... | Q27077698 (fondaparinux) | fondaparinux |
| P769 | significant drug interaction | ... | Q27132753 (tenofovir disoproxil) | tenofovir disoproxil |
| P769 | significant drug interaction | ... | Q47495698 (lisinopril dihydrate) | lisinopril dihydrate |
| P769 | significant drug interaction | ... | Q105969996 (enoxaparin) | enoxaparin |
| P769 | significant drug interaction | ... | Q113368879 (rac-warfarin) | rac-warfarin |
| P769 | significant drug interaction | ... | Q415220 (pemetrexed) | pemetrexed |
| P769 | significant drug interaction | ... | Q415366 (tirofiban) | tirofiban |
| P769 | significant drug interaction | ... | Q415970 (candesartan) | candesartan |
| P769 | significant drug interaction | ... | Q347941 (parecoxib) | parecoxib |
| P769 | significant drug interaction | ... | Q367700 (cyclosporine) | cyclosporine |
| P769 | significant drug interaction | ... | Q388801 (furosemide) | furosemide |
| P769 | significant drug interaction | ... | Q408801 (celecoxib) | celecoxib |
| P769 | significant drug interaction | ... | Q409192 ((RS)-ketoprofen) | (RS)-ketoprofen |
| P769 | significant drug interaction | ... | Q409236 (fluvoxamine) | fluvoxamine |
| P769 | significant drug interaction | ... | Q416132 (betamethasone) | betamethasone |
| P769 | significant drug interaction | ... | Q416232 (prasugrel) | prasugrel |
| P769 | significant drug interaction | ... | Q417222 (methylprednisolone) | methylprednisolone |
| P769 | significant drug interaction | ... | Q407617 (sertraline) | sertraline |
| P769 | significant drug interaction | ... | Q419890 ((±)-flurbiprofen) | (±)-flurbiprofen |
| P769 | significant drug interaction | ... | Q419995 (amiloride) | amiloride |
| P769 | significant drug interaction | ... | Q420262 (rivaroxaban) | rivaroxaban |
| P769 | significant drug interaction | ... | Q422244 (fluoxetine) | fluoxetine |
| P769 | significant drug interaction | ... | Q422252 (dexamethasone) | dexamethasone |
| P769 | significant drug interaction | ... | Q409672 ((RS)-citalopram) | (RS)-citalopram |
| P769 | significant drug interaction | ... | Q410074 (losartan) | losartan |
| P769 | significant drug interaction | ... | Q422212 (budesonide) | budesonide |
| P769 | significant drug interaction | ... | Q422232 (methotrexate) | methotrexate |
| P769 | significant drug interaction | ... | Q408471 (paroxetine) | paroxetine |
| P769 | significant drug interaction | ... | Q408676 (piroxicam) | piroxicam |
| P769 | significant drug interaction | ... | Q423804 (eplerenone) | eplerenone |
| P769 | significant drug interaction | ... | Q423930 (hydrochlorothiazide) | hydrochlorothiazide |
| P769 | significant drug interaction | ... | Q420542 (ticagrelor) | ticagrelor |
| P769 | significant drug interaction | ... | Q421119 (captopril) | captopril |
| P769 | significant drug interaction | ... | Q421156 (olmesartan) | olmesartan |
| P769 | significant drug interaction | ... | Q410237 (clopidogrel) | clopidogrel |
| P769 | significant drug interaction | ... | Q411648 (tacrolimus) | tacrolimus |
| P769 | significant drug interaction | ... | Q481757 (aceclofenac) | aceclofenac |
| P769 | significant drug interaction | ... | Q596022 (quinapril) | quinapril |
| P769 | significant drug interaction | ... | Q422185 (enalapril) | enalapril |
| P769 | significant drug interaction | ... | Q422188 (spironolactone) | spironolactone |
| P769 | significant drug interaction | ... | Q424972 (prednisone) | prednisone |
| P769 | significant drug interaction | ... | Q425207 (nabumetone) | nabumetone |
| P769 | significant drug interaction | ... | Q425289 (chlorthalidone) | chlorthalidone |
| P769 | significant drug interaction | ... | Q411932 ((S)-duloxetine) | (S)-duloxetine |
| P769 | significant drug interaction | ... | Q412050 (prostacyclin) | prostacyclin |
| P769 | significant drug interaction | ... | Q412666 (ramipril) | ramipril |
| P769 | significant drug interaction | ... | Q963093 (sulindac) | sulindac |
| P769 | significant drug interaction | ... | Q1078392 (indapamide) | indapamide |
| P769 | significant drug interaction | ... | Q1169164 ((RS)-bendroflumethiazide) | (RS)-bendroflumethiazide |
| P769 | significant drug interaction | ... | Q1215575 (naproxen) | naproxen |
| P769 | significant drug interaction | ... | Q733186 (telmisartan) | telmisartan |
| P769 | significant drug interaction | ... | Q784717 (eprosartan) | eprosartan |
| P769 | significant drug interaction | ... | Q3563148 (vortioxetine) | vortioxetine |
| P769 | significant drug interaction | ... | Q3655338 (cangrelor) | cangrelor |
| P769 | significant drug interaction | ... | Q414028 (meloxicam) | meloxicam |
| P769 | significant drug interaction | ... | Q414462 (apixaban) | apixaban |
| P769 | significant drug interaction | ... | Q5135114 ((2RS,6RS)-clopamide) | (2RS,6RS)-clopamide |
| P769 | significant drug interaction | ... | Q898407 (venlafaxine) | venlafaxine |
| P769 | significant drug interaction | ... | Q929420 (trandolapril) | trandolapril |
| P769 | significant drug interaction | ... | Q947266 (irbesartan) | irbesartan |
| P769 | significant drug interaction | ... | Q1640947 (phenindione) | phenindione |
| P769 | significant drug interaction | ... | Q1851701 (dalteparin) | dalteparin |
| P769 | significant drug interaction | ... | Q2295855 (eptifibatide) | eptifibatide |
| P769 | significant drug interaction | ... | Q11426176 (prednisolone) | prednisolone |
| P769 | significant drug interaction | ... | Q20817139 (iloprost) | iloprost |
| P769 | significant drug interaction | ... | Q20817252 (tinzaparin) | tinzaparin |
| P769 | significant drug interaction | ... | Q2465218 ((RS)-etodolac) | (RS)-etodolac |
| P769 | significant drug interaction | ... | Q2555245 ((RS)-fenoprofen) | (RS)-fenoprofen |
| P279 | subclass of | ... | Q188724 (non-steroidal anti-inflammatory drug) | non-steroidal anti-inflammatory drug |
| P279 | subclass of | ... | Q408452 (indole alkaloid) | indole alkaloid |
| P2868 | subject has role | ... | Q188724 (non-steroidal anti-inflammatory drug) | non-steroidal anti-inflammatory drug |
| P2868 | subject has role | ... | Q50429907 (cardiovascular agent) | cardiovascular agent |
| P2868 | subject has role | ... | Q545234 (tocolytic uterine relaxants) | tocolytic uterine relaxants |
| P2868 | subject has role | ... | Q17173047 (antigout agent) | antigout agent |
| P2868 | subject has role | ... | Q20522059 (cyclooxygenase inhibitors) | cyclooxygenase inhibitors |
| P2275 | World Health Organisation international non-proprietary name | Monolingualtext | indometacin | ??? |
Why not click here or view trends?
log id: 3020417